Skip to main content
Log in

ETS1 Ameliorates Hyperoxia-Induced Alveolar Epithelial Cell Injury by Regulating the TGM2-Mediated Wnt/β-Catenin Pathway

  • HYPEROXIA-INDUCED LUNG INJURY
  • Published:
Lung Aims and scope Submit manuscript

Abstract

Purpose

Bronchopulmonary dysplasia (BPD) is a chronic lung disease that affects newborns who need oxygen therapy, and high-concentration oxygen therapy may cause neonatal morbidity and mortality in newborns. E26 oncogene homologue 1 (ETS1) and transglutaminase 2 (TGM2) have been reported to be associated with lung cell injury. However, the mechanism of ETS1 in regulating BPD is still unclear.

Methods

Hyperoxia-induced A549 cells to simulate hyperoxia-induced alveolar epithelial cell injury. MTT assays and colony formation assays were performed to investigate the proliferation of A549 cells. Flow cytometry was carried out to quantify the apoptosis of A549 cells. The expression levels of ETS1 and TGM2 were quantified by qRT–PCR. The protein expression levels of ETS1, TGM2, β-catenin, c-Jun and MET were measured by western blot. Overexpression of ETS1, overexpression of TGM2, overexpression of ETS1 with downregulation of TGM2 and overexpression of TGM2 with inhibition of Wnt/β-catenin pathway were performed to investigate the role of ETS1, TGM2 and Wnt/β-catenin pathways in hyperoxia-induced alveolar epithelial cell injury.

Results

Hyperoxia decreased the proliferation and promoted the apoptosis of cells in a time-dependent manner. Moreover, overexpression of ETS1 rescued the effect of hyperoxia on proliferation and apoptosis. In addition, overexpression of TGM2 participated in the regulation of hyperoxia-induced proliferation and apoptosis. ETS1 regulated hyperoxia-induced alveolar epithelial cell injury through the Wnt/β-catenin pathway via TGM2.

Conclusion

ETS1 ameliorates hyperoxia-induced alveolar epithelial cell injury through the TGM2-mediated Wnt/β-catenin pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data Availability

The datasets used or analyzed during the current study are available from the corresponding author on reasonable request.

Code Availability

Not applicable.

Abbreviations

BPD:

Bronchopulmonary dysplasia

NCPAP:

Nasal continuous positive airway pressure

DMEM:

Dulbecco’s modified Eagle’s medium

FBS:

Fetal bovine serum

EST1 :

The E26 oncogene homolog 1

EBS:

ETS binding site

TGM2 :

Transglutaminase 2

References

  1. Haggie S et al (2020) Bronchopulmonary dysplasia: a review of the pulmonary sequelae in the post-surfactant era. J Paediatr Child Health 56(5):680–689

    Article  Google Scholar 

  2. Varghese N, Rios D (2019) Pulmonary hypertension associated with bronchopulmonary dysplasia: a review. Pediatr Allergy Immunol Pulmonol 32(4):140–148

    Article  Google Scholar 

  3. Siffel C et al (2019) Global incidence of bronchopulmonary dysplasia among extremely preterm infants: a systematic literature review. J Matern-Fetal Neonatal Med 34:1721–1731

    Article  Google Scholar 

  4. Morris IP, Goel N, Chakraborty M (2019) Efficacy and safety of systemic hydrocortisone for the prevention of bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis. Eur J Pediatr 178(8):1171–1184

    Article  CAS  Google Scholar 

  5. Mosca F, Colnaghi M, Fumagalli M (2011) BPD: old and new problems. J Matern Fetal Neonatal Med 24(Suppl 1):80–82

    Article  Google Scholar 

  6. Gu CC et al (2019) MiR-532–3p suppresses colorectal cancer progression by disrupting the ETS1/TGM2 axis-mediated Wnt/beta-catenin signaling. Cell Death Dis. https://doi.org/10.1038/s41419-019-1962-x

    Article  PubMed  PubMed Central  Google Scholar 

  7. Guo MH et al (2013) The influence of BCSG1 siRNA on gene expression of BCSG1 in human breast cancer and the expression of S-100A4, ETS1, VEGF and CD105 in human breast tumor. Int J Mol Med 32:S74–S74

    Google Scholar 

  8. Kars MD, Iseri OD, Gunduz U (2010) Drug resistant breast cancer cells overexpress ETS1 gene. Biomed Pharmacother 64(7):458–462

    Article  CAS  Google Scholar 

  9. Kim GC et al (2020) ETS1 suppresses tumorigenesis of human breast cancer via trans-activation of canonical tumor suppressor genes. Front Oncol. https://doi.org/10.3389/fonc.2020.00642

    Article  PubMed  PubMed Central  Google Scholar 

  10. Yang M et al (2017) Angiogenesis-related genes may be a more important factor than matrix metalloproteinases in bronchopulmonary dysplasia development. Oncotarget 8(12):18670–18679

    Article  Google Scholar 

  11. Choi CM et al (2011) Transglutaminase 2 as an independent prognostic marker for survival of patients with non-adenocarcinoma subtype of non-small cell lung cancer. Mol Cancer. https://doi.org/10.1186/1476-4598-10-119

    Article  PubMed  PubMed Central  Google Scholar 

  12. Hadchouel A et al (2008) Matrix metalloproteinase gene polymorphisms and bronchopulmonary dysplasia: identification of MMP16 as a new player in lung development. Plos One 3(9):e3188

    Article  Google Scholar 

  13. Kim JH et al (2012) Effects of transglutaminase 2 inhibition in ventilator-induced lung injury. Respirology 17:65–65

    Article  Google Scholar 

  14. Lee MY et al (2018) Tissue transglutaminase 2 expression is epigenetically regulated in human lung cancer cells and prevents reactive oxygen species-induced apoptosis. Cancer Manag Res 10:2835–2848

    Article  CAS  Google Scholar 

  15. Witsch TJ et al (2014) Transglutaminase 2: a new player in bronchopulmonary dysplasia? Eur Respir J 44(1):109–121

    Article  CAS  Google Scholar 

  16. Wang SH et al (2018) The Wnt7b/beta-catenin signaling pathway is involved in the protective action of calcitonin gene-related peptide on hyperoxia-induced lung injury in premature rats. Cell Mol Biol Lett. https://doi.org/10.1186/s11658-018-0071-7

    Article  PubMed  PubMed Central  Google Scholar 

  17. Syed M et al (2017) Hyperoxia causes miR-34a-mediated injury via angiopoietin-1 in neonatal lungs. Nat Commun 8(1):1173

    Article  Google Scholar 

  18. Abdul-Hafez A, Mohamed T, Uhal BD (2019) Activation of mas restores hyperoxia-induced loss of lung epithelial barrier function through inhibition of apoptosis. J Lung Pulm Respir Res 6(3):58–62

    PubMed  PubMed Central  Google Scholar 

  19. Tiwari KK et al (2014) Differential concentration-specific effects of caffeine on cell viability, oxidative stress, and cell cycle in pulmonary oxygen toxicity in vitro. Biochem Biophys Res Commun 450(4):1345–1350

    Article  CAS  Google Scholar 

  20. Jia X et al (2021) YAP and Wnt3a independently promote AECIIs proliferation and differentiation by increasing nuclear betacatenin expression in experimental bronchopulmonary dysplasia. Int J Mol Med 47(1):195–206

    Article  CAS  Google Scholar 

  21. Yang P et al (2019) TGM2 interference regulates the angiogenesis and apoptosis of colorectal cancer via Wnt/beta-catenin pathway. Cell Cycle 18(10):1122–1134

    Article  CAS  Google Scholar 

  22. Chen G, Sun X, Dong C (2017) RhoA regulates lipopolysaccharideinduced lung cell injury via the Wnt/betacatenin pathway. Mol Med Rep 16(6):8501–8506

    Article  CAS  Google Scholar 

  23. Cheng L et al (2018) Wnt/beta-catenin pathway promotes acute lung injury induced by LPS through driving the Th17 response in mice. Biochem Biophys Res Commun 495(2):1890–1895

    Article  CAS  Google Scholar 

  24. Dasgupta C et al (2009) Hyperoxia-induced neonatal rat lung injury involves activation of TGF-{beta} and Wnt signaling and is protected by rosiglitazone. Am J Physiol Lung Cell Mol Physiol 296(6):L1031–L1041

    Article  CAS  Google Scholar 

Download references

Funding

This work was supported by Youth Fund of Hunan Natural Science Foundation (No. 2019JJ50293) and Hunan Health Commission (No. B2019012).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yan-Ping Chen.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest regarding the publication of this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

408_2021_489_MOESM1_ESM.pdf

Supplementary file1 Schematic diagram: Hyperoxia-induced down-regulation of ETS1 affects the TGM2-mediated Wnt/β-catenin pathway, thereby promoting the apoptosis of alveolar epithelial cell injury and inhibiting proliferation (PDF 155 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, M., Gao, XR., Meng, YN. et al. ETS1 Ameliorates Hyperoxia-Induced Alveolar Epithelial Cell Injury by Regulating the TGM2-Mediated Wnt/β-Catenin Pathway. Lung 199, 681–690 (2021). https://doi.org/10.1007/s00408-021-00489-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-021-00489-9

Keywords

Navigation